223 related articles for article (PubMed ID: 31068152)
21. Association between injectable progestin-only contraceptives and HIV acquisition and HIV target cell frequency in the female genital tract in South African women: a prospective cohort study.
Byrne EH; Anahtar MN; Cohen KE; Moodley A; Padavattan N; Ismail N; Bowman BA; Olson GS; Mabhula A; Leslie A; Ndung'u T; Walker BD; Ghebremichael MS; Dong KL; Kwon DS
Lancet Infect Dis; 2016 Apr; 16(4):441-8. PubMed ID: 26723758
[TBL] [Abstract][Full Text] [Related]
22. Objective Measurement of Inaccurate Condom Use Reporting Among Women Using Depot Medroxyprogesterone Acetate for Contraception.
Heffron R; Parikh UM; Penrose KJ; Mugo N; Donnell D; Celum C; Mellors JW; Baeten JM;
AIDS Behav; 2017 Jul; 21(7):2173-2179. PubMed ID: 27699594
[TBL] [Abstract][Full Text] [Related]
23. Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies.
Ralph LJ; McCoy SI; Shiu K; Padian NS
Lancet Infect Dis; 2015 Feb; 15(2):181-9. PubMed ID: 25578825
[TBL] [Abstract][Full Text] [Related]
24. Statement on injectable contraception.
International Planned Parenthood Federation IPPF
IPPF Med Bull; 1982 Dec; 16(6):3-4. PubMed ID: 12338511
[TBL] [Abstract][Full Text] [Related]
25. Increased Cervical CD4
Lajoie J; Tjernlund A; Omollo K; Edfeldt G; Röhl M; Boily-Larouche G; Cheruiyot J; Kimani M; Kimani J; Oyugi J; Broliden K; Fowke KR
AIDS Res Hum Retroviruses; 2019 Mar; 35(3):236-246. PubMed ID: 30585733
[TBL] [Abstract][Full Text] [Related]
26. Norethisterone Enanthate Increases Mouse Susceptibility to Genital Infection with Herpes Simplex Virus Type 2 and HIV Type 1.
Quispe Calla NE; Vicetti Miguel RD; Torres AR; Trout W; Gabriel JM; Hatfield AM; Aceves KM; Kwiek JJ; Kaur B; Cherpes TL
Immunohorizons; 2020 Feb; 4(2):72-81. PubMed ID: 32047094
[TBL] [Abstract][Full Text] [Related]
27. Hormonal contraceptive use and women's risk of HIV acquisition: priorities emerging from recent data.
Ralph LJ; Gollub EL; Jones HE
Curr Opin Obstet Gynecol; 2015 Dec; 27(6):487-95. PubMed ID: 26536211
[TBL] [Abstract][Full Text] [Related]
28. Effect of progestins on immunity: medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs.
Huijbregts RP; Michel KG; Hel Z
Contraception; 2014 Aug; 90(2):123-9. PubMed ID: 24674041
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics and Pharmacodynamics of Depot Medroxyprogesterone Acetate in African Women Receiving Treatment for Human Immunodeficiency Virus and Tuberculosis: Potential Concern for Standard Dosing Frequency.
Mngqibisa R; Kendall MA; Dooley K; Wu XS; Firnhaber C; Mcilleron H; Robinson J; Cramer Y; Rosenkranz SL; Roa J; Coughlin K; Mawlana S; Badal-Faesen S; Schnabel D; Omoz-Oarhe A; Samaneka W; Godfrey C; Cohn SE;
Clin Infect Dis; 2020 Jul; 71(3):517-524. PubMed ID: 31504342
[TBL] [Abstract][Full Text] [Related]
30. Use of contraceptive depot medroxyprogesterone acetate is associated with impaired cervicovaginal mucosal integrity.
Zalenskaya IA; Chandra N; Yousefieh N; Fang X; Adedipe OE; Jackson SS; Anderson SM; Mauck CK; Schwartz JL; Thurman AR; Doncel GF
J Clin Invest; 2018 Oct; 128(10):4622-4638. PubMed ID: 30222141
[TBL] [Abstract][Full Text] [Related]
31. An updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women.
Polis CB; Curtis KM; Hannaford PC; Phillips SJ; Chipato T; Kiarie JN; Westreich DJ; Steyn PS
AIDS; 2016 Nov; 30(17):2665-2683. PubMed ID: 27500670
[TBL] [Abstract][Full Text] [Related]
32. Cervical inflammation and immunity associated with hormonal contraception, pregnancy, and HIV-1 seroconversion.
Morrison C; Fichorova RN; Mauck C; Chen PL; Kwok C; Chipato T; Salata R; Doncel GF
J Acquir Immune Defic Syndr; 2014 Jun; 66(2):109-17. PubMed ID: 24413042
[TBL] [Abstract][Full Text] [Related]
33. Bone density in long term users of depot medroxyprogesterone acetate.
Gbolade B; Ellis S; Murby B; Randall S; Kirkman R
Br J Obstet Gynaecol; 1998 Jul; 105(7):790-4. PubMed ID: 9692421
[TBL] [Abstract][Full Text] [Related]
34. Brief Report: Dapivirine Vaginal Ring Use Does Not Diminish the Effectiveness of Hormonal Contraception.
Balkus JE; Palanee-Phillips T; Reddy K; Siva S; Harkoo I; Nakabiito C; Kintu K; Nair G; Chappell C; Kiweewa FM; Kabwigu S; Naidoo L; Jeenarain N; Marzinke M; Soto-Torres L; Brown ER; Baeten JM
J Acquir Immune Defic Syndr; 2017 Oct; 76(2):e47-e51. PubMed ID: 28542081
[TBL] [Abstract][Full Text] [Related]
35. Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women.
Baeten JM; Benki S; Chohan V; Lavreys L; McClelland RS; Mandaliya K; Ndinya-Achola JO; Jaoko W; Overbaugh J
AIDS; 2007 Aug; 21(13):1771-7. PubMed ID: 17690576
[TBL] [Abstract][Full Text] [Related]
36. Assessing menopausal status in women aged 40 - 49 using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraception.
Beksinska ME; Smit JA; Kleinschmidt I; Farley TM
S Afr Med J; 2011 Feb; 101(2):131-5. PubMed ID: 21678742
[TBL] [Abstract][Full Text] [Related]
37. Hormonal contraception and HIV acquisition among women: an updated systematic review.
Curtis KM; Hannaford PC; Rodriguez MI; Chipato T; Steyn PS; Kiarie JN
BMJ Sex Reprod Health; 2020 Jan; 46(1):8-16. PubMed ID: 31919239
[TBL] [Abstract][Full Text] [Related]
38. Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): assessment of return of ovulation after three monthly injections in surgically sterile women.
Rahimy MH; Ryan KK
Contraception; 1999 Oct; 60(4):189-200. PubMed ID: 10640165
[TBL] [Abstract][Full Text] [Related]
39. Regular Use of Depot Medroxyprogesterone Acetate Causes Thinning of the Superficial Lining and Apical Distribution of Human Immunodeficiency Virus Target Cells in the Human Ectocervix.
Edfeldt G; Lajoie J; Röhl M; Oyugi J; Åhlberg A; Khalilzadeh-Binicy B; Bradley F; Mack M; Kimani J; Omollo K; Wählby C; Fowke KR; Broliden K; Tjernlund A
J Infect Dis; 2022 Apr; 225(7):1151-1161. PubMed ID: 32780807
[TBL] [Abstract][Full Text] [Related]
40. WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
Contraception; 1982 Jan; 25(1):1-11. PubMed ID: 6460593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
